These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10360595)
41. Foscarnet treatment in various cytomegalovirus infections. Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868 [TBL] [Abstract][Full Text] [Related]
42. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Chrisp P; Clissold SP Drugs; 1991 Jan; 41(1):104-29. PubMed ID: 1706982 [TBL] [Abstract][Full Text] [Related]
43. Antiviral Drugs and Acute Kidney Injury (AKI). Leowattana W Infect Disord Drug Targets; 2019; 19(4):375-382. PubMed ID: 31288730 [TBL] [Abstract][Full Text] [Related]
44. Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection. Mihm J; Leyking S; Dirks J; Smola S; Fliser D; Sester U; Sester M; Wilkens H; Rissland J J Clin Virol; 2016 Sep; 82():5-8. PubMed ID: 27389910 [TBL] [Abstract][Full Text] [Related]
45. Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation. Wang H; Zhu L; Xue M; Liu J; Guo Z Biol Blood Marrow Transplant; 2009 Apr; 15(4):519-20. PubMed ID: 19285642 [No Abstract] [Full Text] [Related]
46. Foscarnet-induced penile ulceration. Torres T; Fernandes I; Sanches M; Selores M Acta Dermatovenerol Alp Pannonica Adriat; 2011; 20(1):39-40. PubMed ID: 21879205 [TBL] [Abstract][Full Text] [Related]
47. [Study of the biopsied nephrotic syndrome for 20 years in the Cadiz Bay Area: histological correspondence, renal prognosis and clinical prognostic factors]. Quirós PL; Ceballos M; Remón C; Lozano A; del Castillo R; Aznar E; Pérez Pérez-Ruilópez MA; Rivero M; Fernández Ruiz E Nefrologia; 2005; 25(2):147-54. PubMed ID: 15912651 [TBL] [Abstract][Full Text] [Related]
48. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. ; N Engl J Med; 1992 Jan; 326(4):213-20. PubMed ID: 1345799 [TBL] [Abstract][Full Text] [Related]
52. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829 [TBL] [Abstract][Full Text] [Related]
53. Safety and efficacy of foscarnet for the management of ganciclovir-resistant or refractory cytomegalovirus infections: A single-center study. Pierce B; Richardson CL; Lacloche L; Allen A; Ison MG Transpl Infect Dis; 2018 Apr; 20(2):e12852. PubMed ID: 29380479 [TBL] [Abstract][Full Text] [Related]
54. A penile ulceration in a patient with the acquired immunodeficiency syndrome. Foscarnet-induced penile ulceration. Fitzgerald E; Goldman HM; Miller WG; Purcell SM Arch Dermatol; 1995 Dec; 131(12):1449, 1452. PubMed ID: 7492139 [No Abstract] [Full Text] [Related]
55. [Systemic cytomegalovirus infection: changes in serum calcium and magnesium levels with foscarnet treatment]. Marzal-Alfaro MB; Manrique-Rodríguez S; Alcaraz Romero A; García San Prudencio M; Fernández-Llamazares CM An Pediatr (Barc); 2015 Jan; 82(1):e170-4. PubMed ID: 24785445 [TBL] [Abstract][Full Text] [Related]
56. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group. Parente F; Bianchi Porro G Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631 [TBL] [Abstract][Full Text] [Related]
58. Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology. Chiu HF; Chen HC; Lu KC; Shu KH; BMC Nephrol; 2018 Jan; 19(1):6. PubMed ID: 29320993 [TBL] [Abstract][Full Text] [Related]
59. Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study. Bregante S; Bertilson S; Tedone E; Van Lint MT; Trespi G; Mordini N; Berisso G; Gualandi F; Lamparelli T; Figari O; Benvenuto F; Raiola AM; Bacigalupo A Bone Marrow Transplant; 2000 Jul; 26(1):23-9. PubMed ID: 10918402 [TBL] [Abstract][Full Text] [Related]
60. Analysis of 4931 renal biopsy data in central China from 1994 to 2014. Xu X; Ning Y; Shang W; Li M; Ku M; Li Q; Li Y; Dai W; Shao J; Zeng R; Han M; He X; Yao Y; Lv Y; Liu X; Ge S; Xu G Ren Fail; 2016 Aug; 38(7):1021-30. PubMed ID: 27193055 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]